Jennifer Reynolds
Stories (22)
Filter by community
Asia Pacific Pharmaceutical Drug Delivery Market Poised to Reach US$687.9 Million by 2031. AI-Generated.
The Asia Pacific pharmaceutical drug delivery market is experiencing transformative growth, advancing from US$479.7 million in 2026 to a projected US$687.9 million by 2031, representing a robust compound annual growth rate (CAGR) of 7.5% throughout the forecast period. This expansion—up from US$457.9 million in 2025—reflects fundamental shifts in regional healthcare infrastructure, disease management strategies, and therapeutic delivery innovation that C-suite executives and strategic decision-makers must understand to capitalize on emerging opportunities.
By Jennifer Reynolds6 days ago in Futurism
Europe In Vitro Diagnostics Market Set to Reach USD 49.49 Billion by 2031. AI-Generated.
The Europe in vitro diagnostics (IVD) market is entering a decisive growth phase as healthcare systems, policymakers, and life sciences leaders intensify investments in early detection, automation, and precision medicine. Valued at USD 31.43 billion in 2025 and USD 33.83 billion in 2026, the market is projected to expand at a resilient CAGR of 7.9% from 2026 to 2031, reaching USD 49.49 billion by the end of the forecast period.
By Jennifer Reynolds12 days ago in Futurism
US Injectable Drug Delivery Market Set to Reach USD 465.15 Billion by 2031. AI-Generated.
The US injectable drug delivery market is entering a decisive growth phase as biologics, long-acting therapies, and patient-centric self-administration systems reshape how advanced medicines are developed, manufactured, and delivered. Valued at USD 285.81 billion in 2025 and USD 309.90 billion in 2026, the market is projected to reach USD 465.15 billion by 2031, expanding at a resilient CAGR of 8.5%.
By Jennifer Reynolds12 days ago in Futurism
U.S. AI in Healthcare Market Set to Surge to USD 43.30 Billion by 2030. AI-Generated.
The U.S. artificial intelligence (AI) in healthcare market is entering a decisive expansion phase, driven by structural workforce shortages, escalating operational complexity, and urgent demand for automation and clinical precision. Valued at USD 5.98 billion in 2024 and USD 8.65 billion in 2025, the market is projected to grow at a resilient CAGR of 38.0% from 2025 to 2030, reaching USD 43.30 billion by the end of the forecast period.
By Jennifer Reynolds12 days ago in Futurism
Asia Pacific Telehealth & Telemedicine Market Set to Surpass USD 40.8 Billion by 2030. AI-Generated.
The Asia Pacific telehealth and telemedicine market is entering a decisive growth phase, positioning digital healthcare as a core pillar of regional health system modernization and enterprise healthcare strategy.
By Jennifer Reynolds12 days ago in Futurism
Europe Telehealth & Telemedicine Market on Track to Exceed US$42 Billion by 2030. AI-Generated.
The Europe telehealth and telemedicine market is transitioning from rapid adoption to structural integration within national healthcare systems and enterprise health strategies. Valued at US$22.01 billion in 2024 and US$24.76 billion in 2025, the market is projected to reach US$42.04 billion by 2030, expanding at a resilient CAGR of 11.2% from 2025 to 2030.
By Jennifer Reynolds12 days ago in Futurism
Top Biosimilars Companies in 2025. AI-Generated.
The global biosimilars market is expected to grow from USD 35.04 billion in 2025 to USD 72.29 billion by 2035, registering a compound annual growth rate (CAGR) of 7.5% during the forecast period. This growth is driven by rising adoption rates, supportive regulatory frameworks, and a growing acceptance among healthcare professionals to include biosimilars in treatment regimens.
By Jennifer Reynolds4 months ago in Journal
Top Digital Health Companies in 2025 . AI-Generated.
Prominent players in the market include Medtronic (Ireland), Abbott (US), OMRON Healthcare, Inc. (Japan), Koninklijke Philips N.V. (Netherlands), Apple Inc. (US), Fitbit (US), Dexcom, Inc. (US), Boston Scientific Corporation (US), Masimo (US), Teladoc Health, Inc. (US), American Well (US), Hims & Hers Health, Inc. (US), Headspace inc. (US), Noom, Inc. (US), Cerebral Inc. (US), Epic System Corporation (US), Omada Health Inc. (US), Oracle (US), Click Therapeutics, Inc. (US), Welldoc, Inc. (US), and EverlyWell (US).
By Jennifer Reynolds4 months ago in Journal
Synthetic Biology Market worth $31.52 billion by 2029. AI-Generated.
The report "Synthetic Biology Market by Tools (Oligonucleotides, Enzymes, Synthetic Cells), Technology (Sequencing, Bioinformatics), Applications (Drug Discovery, Tissue Regeneration, Biofuel, Food, Agriculture, Consumer Care, Environmental) - Global Forecast to 2029", is estimated to expand to a value of USD 31.52 billion by 2029 from USD 12.33 billion in 2024, with a significant CAGR of 20.6%. Some of the prominent factors driving the growth of the market are the rising demand for bio-based products and rising funding in R&D and collaborations. Furthermore, Advancements in synthetic biology and the diverse applications of synthetic biology are expected to provide lucrative market growth. The demand for synthetic DNA and oligonucleotides is growing, driven by diversified applications in research, diagnostics, and therapeutic development. This factor is likely to contribute to the growth of synthetic biology, particularly in the healthcare and biotechnology field.
By Jennifer Reynolds4 months ago in Journal
Top CRISPR Companies in 2025. AI-Generated.
The global CRISPR market is projected to increase from USD 3.21 billion in 2025 to USD 5.47 billion by 2030, registering a robust CAGR of 11.2% during the forecast period. The market is highly competitive, with several major players striving to expand their market presence. Prominent companies operating in the CRISPR market include Thermo Fisher Scientific Inc. (US), Agilent Technologies Inc. (US), Merck KGaA (Germany), and GenScript (US), among others. These leading players are pursuing a range of growth strategies—both organic and inorganic—such as partnerships, agreements, expansions, and acquisitions, to strengthen their market position and drive innovation in CRISPR technologies.
By Jennifer Reynolds4 months ago in Journal
Top defibrillator Companies in 2025. AI-Generated.
The global defibrillator market is projected to grow from USD 11.99 billion in 2025 to USD 16.44 billion by 2030, registering a CAGR of 6.5% during the forecast period. Market growth is driven by the rising incidence of cardiac arrest among patients with cardiovascular diseases, increasing government and private initiatives to install defibrillators in public spaces for improved emergency response, and expanding training and awareness programs related to defibrillator use. Additionally, advancements in subcutaneous implantable cardioverter-defibrillators (S-ICDs), MRI-compatible ICDs and CRT-Ds, along with the ongoing enhancement of healthcare infrastructure in emerging economies, are expected to further fuel market expansion.
By Jennifer Reynolds4 months ago in Journal
United States Single-Use Bioreactors Market Poised for Transformative Growth Driven by Innovation and Industry Adoption . AI-Generated.
The American single-use bioreactors industry continues to demonstrate remarkable momentum as biopharmaceutical manufacturers increasingly pivot toward flexible, cost-effective production solutions. The country maintains its position as the global leader in this transformative market segment, driven by substantial research and development investments, innovative manufacturing practices, and a robust biopharmaceutical ecosystem.
By Jennifer Reynolds4 months ago in Journal
